Intestinimonas massiliensis

Information

Microbe Identification

Intestinimonas massiliensis

Microbe id: PMDBM2021562
Level: Species
NCBI Taxonomy ID:
Taxonomy Species: Intestinimonas massiliensis [1673721]
Taxonomy Genus: Intestinimonas [1392389]
Taxonomy Family: n.a. [n.a.]

Interactions between microbe and active substances


ⓘ How do we work out MGCs and BGCs of one specific species?


Metabolic gene clusters of Intestinimonas massiliensis

No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View gutSMASH Detailed Result
Biosynthetic gene clusters of Intestinimonas massiliensis


No data available

n.s. indicates that no significant matches were found by KnownClusterBlast.

View antiSMASH Detailed Result
Map of Intestinimonas massiliensis distribution in human body and influence of diseases distribution in human body and influence of diseases


ⓘ How do you use the microbe distribution map?
ⓘ How did we get the relative abundance and microbe change in the map?
bodymap Oral Nose Esophagus Stomach Trachea Upper respiratory tract Vagina Blood Urethral Lung Cervix Rectum Skin Duodenum Fallopian tube Fallopian tube Peritoneal fluid Uterus Ear Ovary Ovary Colon Ileum Cecum
Disease id Bodysite Relative abundance (%) Disease name Microbe_change

Relative abundance landscape of Intestinimonas massiliensis in human gut microbiota samples



Abundance lanscape in healthy samples (by patients' age)
Abundance lanscape in healthy samples (by patients' country)
Abundance lanscape in disease samples
⚠ About the relative abundance profile

The relative taxonomical abundance data (pre-processed using a unified analysis pipeline) was retrieved from curatedMetagenomicData resource [Edoardo Pasolli, et al. Nat Methods. 2017;14(11):1023-1024]. Data retrieved here was pre-processed as unified relative abundance: at each taxonomic level (e.g., species, genus, family), the sum of microbial abundance of individual microbiota sample was 1, and relative abundance of each microbe was log10 transformed [relative abundance ranges from -7 to 0].

Healthy samples and disease samples (only disease types with >= 20 samples were included) were grouped by age periods, patients?country, or disease type to plot the relative abundance landscape using ggplot2 R package.



Comparative analysis of human gut metagenomes between disease and healthy samples of Intestinimonas massiliensis

Data source: Phenotype comparisons were obtained from GMrepo . We summarized all comparisons that included healthy samples as controls and overlapped with microbes represented in MASI.

Note: LDA scores below 0 indicate taxa enriched in healthy samples, whereas scores above 0 indicate taxa enriched in disease samples.

Disease Project ID LDA score Experiment Type
Kidney Failure, Chronic PRJNA449784🔗2.52443090005966mNGS
Kidney Failure, Chronic PRJEB65297🔗2.56552686898145mNGS
Kidney Failure, Chronic PRJNA449784🔗2.76869685776939mNGS
Kidney Failure, Chronic PRJEB65297🔗3.28921087195022mNGS
Hypertension PRJNA509999🔗2.42712811973097mNGS
Diabetes Mellitus, Type 2 PRJDB9608🔗-3.544908053490916S
Diarrhea PRJEB14038🔗-2.46866628187631mNGS
Diarrhea PRJEB14038🔗-2.178896386977mNGS
Colorectal Neoplasms PRJEB70916🔗-2.45610820723137mNGS
Colorectal Neoplasms PRJNA936589🔗2.48507790124051mNGS
Colorectal Neoplasms PRJNA1138893🔗2.49158772910204mNGS
Colorectal Neoplasms PRJEB70916🔗2.52459228453195mNGS
Colorectal Neoplasms PRJEB53415🔗2.599084246755816S
Colorectal Neoplasms PRJNA464414🔗3.3286211938507116S
Parkinson Disease PRJNA762484🔗2.53559137230273mNGS
Parkinson Disease PRJNA588035🔗2.54553436574871mNGS
Parkinson Disease PRJNA762484🔗3.0470071297894mNGS
Colitis, Ulcerative PRJNA804422🔗-3.8161039493197116S
Colitis, Ulcerative PRJNA398089🔗2.91715233791929mNGS
Campylobacter Infections PRJNA660443🔗-2.85555258442mNGS
Spondylarthritis PRJNA342486🔗-2.8359559900519716S
Feeding and Eating Disorders PRJEB55035🔗3.471498778158216S
Prostatic Neoplasms PRJNA762994🔗-2.8550414648923516S
Tic Disorders PRJNA780788🔗-3.1816893359285416S
Crohn Disease PRJNA820056🔗-2.7214969272468816S
Crohn Disease PRJNA793776🔗-2.43046418831383mNGS
Crohn Disease PRJNA398089🔗-2.06460878367mNGS
Crohn Disease PRJNA993675🔗2.61063899338347mNGS
Polycystic Ovary Syndrome PRJNA530971🔗-2.91250732441565mNGS
Purpura, Thrombocytopenic, Idiopathic PRJNA858062🔗2.82305130528121mNGS
Dermatitis, Atopic PRJEB45443🔗-2.66221019430185mNGS
Dermatitis, Atopic PRJEB45443🔗-2.24015214266288mNGS
Arthritis, Rheumatoid PRJNA786110🔗-3.211564495576316S
Arthritis, Rheumatoid PRJNA896336🔗2.43377344586944mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗2.18484286006041mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗2.69509178693876mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗2.9579040284517mNGS
Fatigue Syndrome, Chronic PRJNA878603🔗3.0533025492978mNGS
Fatigue Syndrome, Chronic PRJNA751448🔗3.05680371429909mNGS
Fatigue Syndrome, Chronic PRJNA379741🔗3.50662862994722mNGS
Anorexia Nervosa PRJEB11199🔗2.1135213806985216S
Anorexia Nervosa PRJEB38930🔗3.2321032712722716S
Neuroblastoma PRJEB63351🔗3.21908337870521mNGS
Depressive Disorder, Major PRJNA762199🔗2.50782413572102mNGS
Gastroesophageal Reflux PRJNA993632🔗2.82753020072465mNGS
Clostridium Infections PRJNA648321🔗3.36558115332166mNGS
Atrial Fibrillation PRJNA728204🔗3.8690375908555316S
Lung Neoplasms PRJNA507734🔗3.3877105761353516S
Glomerulonephritis, IGA PRJNA785415🔗3.1156191093803316S
Liver Cirrhosis PRJNA861246🔗3.0016339046924216S
Cystic Fibrosis PRJNA314903🔗-3.0531130843169mNGS
Cystic Fibrosis PRJNA314903🔗-2.61793667014489mNGS
Obesity PRJNA1125836🔗-2.87711158386543mNGS
Retinal Artery Occlusion PRJEB24557🔗-3.19597087340325mNGS
Renal Insufficiency, Chronic PRJEB65297🔗2.28524048325297mNGS
Renal Insufficiency, Chronic PRJEB65297🔗2.92586758919351mNGS
COVID-19 PRJNA769052🔗-2.9351988037940316S
COVID-19 PRJNA624223🔗-2.87684277498314mNGS
COVID-19 PRJNA689961🔗-2.1944778731631mNGS
COVID-19 PRJDB13214🔗2.68979266111495mNGS

Microbe-Therapeutic Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of therapeutic substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of therapeutic substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Therapeutic substance that metabolized by Intestinimonas massiliensis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Therapeutic Substances that affect the Intestinimonas massiliensis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)


Drug involved metabolizing or transporting reactions that are carried out by Intestinimonas massiliensis

No data available!

ⓘ How do we get these drug reactions?

To obtain the reactions associated with therapeutic substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGORA2 [Ref: Nature Biotechnology, 41 (2023) 1320?331] database.
Identifying Drug-Associated Reactions: Next, we extracted all reactions that are linked to therapeutic substances from these reconstructions. This involved filtering and identifying reactions specifically related to drug metabolism and transport.
Linking Reaction to Microbes: Utilizing the identified reaction related genes (UidA, Tdc etc.), we machted the corresponding drug-associated reactions to existing microbes in the reconstructions in AGORA2. We could link the presence of these genes in different microbes to the potential for those microbes to carry out the corresponding drug-related reactions.
Putative Drug Reactions: As a result, the drug reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with therapeutic substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGORA2)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGORA2, allowing access to the original .mat files. For more details, visit the AGORA2 repository.

# Model Download
No records found

Detailed Information of drug reactions

Metabolism
Transport
Drug Substrate Drug Metabolite Gene responsible for the reaction Reaction Description Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Substance Name Gene responsible for the reaction Reaction Description Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Herbal Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of herbal substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of herbal substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Traditional medicines/herbs/herbal compounds that metabolized by Intestinimonas massiliensis


Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Traditional medicines/herbs/herbal compounds that affect the Intestinimonas massiliensis



Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)

Microbe-Dietary Substance associations are summarized based on THREE types of association evidence, these include:

Association of microbe alteration of dietary substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of dietary substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.
Association of metabolic reactions of microbes (newly updated in MASI v2.0); This part of data came from microbe metabolic reconstructions based on genome via AGREDA [Ref:Nature Communications, 12 (2021) 4728]. A microbe and a specific substance will be associated when the microbe carries a specific gene whose product can metabolize the substance.





Dietary Substances alter the abundance of Intestinimonas massiliensis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)





Dietary substance that metabolized by Intestinimonas massiliensis

Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)




Dietary Substance involved metabolizing or transporting reactions that are carried out by Intestinimonas massiliensis

ⓘ How do we get these diet reactions?

To obtain the reactions associated with dietary substances, we followed a multi-step process:
Downloading Reconstructions: We started by downloading microbial genome-scale metabolic reconstructions from the AGREDA [Ref:Nature Communications, 12 (2021) 4728] database.
Identifying Diet-Associated Reactions: Next, we extracted all reactions that are linked to dietary substances from these reconstructions. This involved filtering and identifying reactions specifically related to dietary substance metabolism and transport.
Linking Reactions to Microbes: Using the identified related genes (e.g., UidA, Tdc) for each drug metabolite reaction, we matched these reactions to microbes possessing the corresponding genes. This allowed us to link the presence of these genes in different microbes to their potential for carrying out the associated drug-related reactions.
Putative Drug Reactions: As a result, the diet reactions identified in this manner are putative, meaning they are inferred based on the presence of specific gene sequences. This provides a hypothetical but informed prediction of the microbial capability to interact with dietary substances.



Statistical Charts
Detailed Information in Table
Original GEM Files (AGREDA)

Classification of Metabolizing or Transporting Related Reactions

Pie Chart of Functionally Related Protein Families

We provide links to the Genomic-Scale Metabolic Models (GEMs) used in this part, sourced from AGREDA, allowing access to the original .xml files. For more details, visit the AGREDA repository.

# Model View
No records found

Detailed Information of diet reactions

Metabolism
Transport
Diet Substrate Enzyme Reaction Formula Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name
Dietary Substance Name Reaction Name Reaction Subsystem Subsystem Class type Subsystem Class level 1 Subsystem Class level 2 Subsystem Class level 3 Reference (PubMed ID) Microbe Name




Microbe-Environmental Substance associations are summarized based on TWO types of association evidence, these include:

Association of microbe alteration of environmental substances; Microbe and a specific substance will be associated when the microbe can metabolize the substance.
Association of environmental substance alteration of microbes; Microbe and a specific substance will be associated when the substance can make the abundance of a microbe increase or decrease.





Environmental Substances that metabolized by Intestinimonas massiliensis



Microbe Name Substance Name Substance Category Substance Subcategory Metabolism Type Metabolites Effects on Substance Experimental System Experimental Organism Experimental Disease Condition Alteration Mechanism Alteration Outcome Reference (PubMed ID)




Environmental Substances that affect the Intestinimonas massiliensis


Microbe Name Substance Name Substance Category Substance Subcategory Substance Details Effect on Microbe Effect Strength Experimental System Experimental Organism Experimental Disease Condition Reference (PubMed ID)
ⓘ Background And User Guideline

Microbe Taxonomy level Species Quorum Sensing (QS) Language QS Language Class Total No. of QS Languages of the Species Reference (PubMed ID)


Diseases associated with the microbe Intestinimonas massiliensis


No data available

Microbiota Site Disease Name Disease Association Class Disease Associated Abundence Change Reference (PubMed ID)



Landscape of Bacteria-Substance-Disease Interaction/Association Network



ⓘ How is the network built?